Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Bahra

Showing results (51-60 of 176) with videos related to

Pageof 18
Sort By:
Transplantation|February 14, 2007
Fibrosis progression in hepatitis C positive liver recipients after sustained virologic response to antiviral combination therapy (interferon-ribavirin therapy)Marcus Bahra, Ulf P Neumann, Dietmar Jacob, et al.
Transplantation|March 14, 2012
Role of IL28B polymorphism in the development of hepatitis C virus-induced hepatocellular carcinoma, graft fibrosis, and posttransplant antiviral therapyDennis Eurich, Sabine Boas-Knoop, Marcus Bahra, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|May 25, 2011
Treatment of hepatitis C-virus-reinfection after liver transplant with silibinin in nonresponders to pegylated interferon-based therapyDennis Eurich, Marcus Bahra, Thomas Berg, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 7, 2018
Strengths, Weaknesses, Opportunities, and Threats of Centralized Pancreatic Surgery: a Single-Center Analysis of 3000 Consecutive Pancreatic ResectionsFritz Klein, Uwe Pelzer, Rosa Bianca Schmuck, et al.
Anticancer Research|September 9, 2018
Clinicopathological Stratification and Long-term Follow-up of Patients with Periampullary CarcinomasRosa B Schmuck, Christian Brokat, Andreas Andreou, et al.
Digestive Diseases and Sciences|October 3, 2009
Antiviral treatment of patients with recurrent hepatitis C after liver transplantation with pegylated interferonSven C Schmidt, Marcus Bahra, Sandra Bayraktar, et al.
Annals of Transplantation|September 23, 2008
Mayo risk score for primary biliary cirrhosis: a useful tool for the prediction of course after liver transplantation?Dietmar A Jacob, Marcus Bahra, Sven C Schmidt, et al.
Clinical Transplantation|April 28, 2006
Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patientsDietmar A Jacob, Ulf P Neumann, Marcus Bahra, et al.
BMC Cancer|March 20, 2014
Intensified chemotherapy and simultaneous treatment with heparin in outpatients with pancreatic cancer - the CONKO 004 pilot trialUwe Pelzer, Andreas Hilbig, Jens M Stieler, et al.
Anticancer Research|September 6, 2017
Incidence and Oncological Implications of Previously Undetected Tumor Multicentricity Following Pancreaticoduodenectomy for Pancreatic Adenocarcinoma in Patients Undergoing Salvage PancreatectomyAndreas Andreou, Fritz Klein, Rosa B Schmuck, et al.
Pageof 18

Showing results (51-60 of 176) with videos related to

Sort By:
Pageof 18
Transplantation|February 14, 2007
Fibrosis progression in hepatitis C positive liver recipients after sustained virologic response to antiviral combination therapy (interferon-ribavirin therapy)Marcus Bahra, Ulf P Neumann, Dietmar Jacob, et al.
Transplantation|March 14, 2012
Role of IL28B polymorphism in the development of hepatitis C virus-induced hepatocellular carcinoma, graft fibrosis, and posttransplant antiviral therapyDennis Eurich, Sabine Boas-Knoop, Marcus Bahra, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|May 25, 2011
Treatment of hepatitis C-virus-reinfection after liver transplant with silibinin in nonresponders to pegylated interferon-based therapyDennis Eurich, Marcus Bahra, Thomas Berg, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 7, 2018
Strengths, Weaknesses, Opportunities, and Threats of Centralized Pancreatic Surgery: a Single-Center Analysis of 3000 Consecutive Pancreatic ResectionsFritz Klein, Uwe Pelzer, Rosa Bianca Schmuck, et al.
Anticancer Research|September 9, 2018
Clinicopathological Stratification and Long-term Follow-up of Patients with Periampullary CarcinomasRosa B Schmuck, Christian Brokat, Andreas Andreou, et al.
Digestive Diseases and Sciences|October 3, 2009
Antiviral treatment of patients with recurrent hepatitis C after liver transplantation with pegylated interferonSven C Schmidt, Marcus Bahra, Sandra Bayraktar, et al.
Annals of Transplantation|September 23, 2008
Mayo risk score for primary biliary cirrhosis: a useful tool for the prediction of course after liver transplantation?Dietmar A Jacob, Marcus Bahra, Sven C Schmidt, et al.
Clinical Transplantation|April 28, 2006
Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patientsDietmar A Jacob, Ulf P Neumann, Marcus Bahra, et al.
BMC Cancer|March 20, 2014
Intensified chemotherapy and simultaneous treatment with heparin in outpatients with pancreatic cancer - the CONKO 004 pilot trialUwe Pelzer, Andreas Hilbig, Jens M Stieler, et al.
Anticancer Research|September 6, 2017
Incidence and Oncological Implications of Previously Undetected Tumor Multicentricity Following Pancreaticoduodenectomy for Pancreatic Adenocarcinoma in Patients Undergoing Salvage PancreatectomyAndreas Andreou, Fritz Klein, Rosa B Schmuck, et al.
Pageof 18